These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 10362843

  • 1. O-Glycosylation of the V2 vasopressin receptor.
    Sadeghi H, Birnbaumer M.
    Glycobiology; 1999 Jul; 9(7):731-7. PubMed ID: 10362843
    [Abstract] [Full Text] [Related]

  • 2. Appropriate polarization following pharmacological rescue of V2 vasopressin receptors encoded by X-linked nephrogenic diabetes insipidus alleles involves a conformation of the receptor that also attains mature glycosylation.
    Tan CM, Nickols HH, Limbird LE.
    J Biol Chem; 2003 Sep 12; 278(37):35678-86. PubMed ID: 12824183
    [Abstract] [Full Text] [Related]

  • 3. A serine cluster prevents recycling of the V2 vasopressin receptor.
    Innamorati G, Sadeghi HM, Tran NT, Birnbaumer M.
    Proc Natl Acad Sci U S A; 1998 Mar 03; 95(5):2222-6. PubMed ID: 9482866
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. An X-linked NDI mutation reveals a requirement for cell surface V2R expression.
    Sadeghi HM, Innamorati G, Birnbaumer M.
    Mol Endocrinol; 1997 Jun 03; 11(6):706-13. PubMed ID: 9171234
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A dileucine sequence and an upstream glutamate residue in the intracellular carboxyl terminus of the vasopressin V2 receptor are essential for cell surface transport in COS.M6 cells.
    Schülein R, Hermosilla R, Oksche A, Dehe M, Wiesner B, Krause G, Rosenthal W.
    Mol Pharmacol; 1998 Sep 03; 54(3):525-35. PubMed ID: 9730911
    [Abstract] [Full Text] [Related]

  • 9. A role for K268 in V2R folding.
    Gouill CL, Darden T, Madziva MT, Birnbaumer M.
    FEBS Lett; 2005 Sep 12; 579(22):4985-90. PubMed ID: 16115624
    [Abstract] [Full Text] [Related]

  • 10. A fully active nonglycosylated V2 vasopressin receptor.
    Innamorati G, Sadeghi H, Birnbaumer M.
    Mol Pharmacol; 1996 Sep 12; 50(3):467-73. PubMed ID: 8794883
    [Abstract] [Full Text] [Related]

  • 11. Molecular aspects of vasopressin receptor function.
    Schöneberg T, Kostenis E, Liu J, Gudermann T, Wess J.
    Adv Exp Med Biol; 1998 Sep 12; 449():347-58. PubMed ID: 10026824
    [Abstract] [Full Text] [Related]

  • 12. Derlin-1 and p97/valosin-containing protein mediate the endoplasmic reticulum-associated degradation of human V2 vasopressin receptors.
    Schwieger I, Lautz K, Krause E, Rosenthal W, Wiesner B, Hermosilla R.
    Mol Pharmacol; 2008 Mar 12; 73(3):697-708. PubMed ID: 18048502
    [Abstract] [Full Text] [Related]

  • 13. Processing and ligand-induced modifications of the V2 vasopressin receptor.
    Sadeghi HM, Innamorati G, Esqueda E, Birnbaumer M.
    Adv Exp Med Biol; 1998 Mar 12; 449():339-46. PubMed ID: 10026823
    [Abstract] [Full Text] [Related]

  • 14. Vasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function.
    Oksche A, Schülein R, Rutz C, Liebenhoff U, Dickson J, Müller H, Birnbaumer M, Rosenthal W.
    Mol Pharmacol; 1996 Oct 12; 50(4):820-8. PubMed ID: 8863826
    [Abstract] [Full Text] [Related]

  • 15. Single amino acid substitutions and deletions that alter the G protein coupling properties of the V2 vasopressin receptor identified in yeast by receptor random mutagenesis.
    Erlenbach I, Kostenis E, Schmidt C, Serradeil-Le Gal C, Raufaste D, Dumont ME, Pausch MH, Wess J.
    J Biol Chem; 2001 Aug 03; 276(31):29382-92. PubMed ID: 11375990
    [Abstract] [Full Text] [Related]

  • 16. Palmitoylation of the V2 vasopressin receptor.
    Sadeghi HM, Innamorati G, Dagarag M, Birnbaumer M.
    Mol Pharmacol; 1997 Jul 03; 52(1):21-9. PubMed ID: 9224808
    [Abstract] [Full Text] [Related]

  • 17. Structural and functional analysis of the canine histamine H2 receptor by site-directed mutagenesis: N-glycosylation is not vital for its action.
    Fukushima Y, Oka Y, Saitoh T, Katagiri H, Asano T, Matsuhashi N, Takata K, van Breda E, Yazaki Y, Sugano K.
    Biochem J; 1995 Sep 01; 310 ( Pt 2)(Pt 2):553-8. PubMed ID: 7544576
    [Abstract] [Full Text] [Related]

  • 18. Effect of N-glycosylation on ligand binding affinity of rat V1a vasopressin receptor.
    Lee KH, Ahn JI, Yu DH, Jeong HS, Lee SH, Kim KS, Chung IY, Kim JH, Lee YS.
    Biochem Biophys Res Commun; 2001 Aug 31; 286(4):707-13. PubMed ID: 11520055
    [Abstract] [Full Text] [Related]

  • 19. Diverse vasopressin V2 receptor functionality underlying partial congenital nephrogenic diabetes insipidus.
    Faerch M, Christensen JH, Rittig S, Johansson JO, Gregersen N, de Zegher F, Corydon TJ.
    Am J Physiol Renal Physiol; 2009 Dec 31; 297(6):F1518-25. PubMed ID: 19812297
    [Abstract] [Full Text] [Related]

  • 20. Properties of the human arginine vasopressin V2 receptor after site-directed mutagenesis of its putative palmitoylation site.
    Schülein R, Liebenhoff U, Müller H, Birnbaumer M, Rosenthal W.
    Biochem J; 1996 Jan 15; 313 ( Pt 2)(Pt 2):611-6. PubMed ID: 8573100
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.